Variation in simian immunodeficiency virus env V1 region in simian AIDS-Associated lymphoma

被引:14
|
作者
Fortgang, IS
Rege, T
Baskin, GB
Murphey-Corb, M
Levy, LS
机构
[1] Tulane Univ, Sch Med, Dept Microbiol & Immunol, Hlth Sci Ctr, New Orleans, LA 70112 USA
[2] Tulane Univ, Hlth Sci Ctr, Dept Surg, New Orleans, LA 70112 USA
[3] Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, New Orleans, LA 70112 USA
[4] Tulane Univ, Hlth Sci Ctr, Tulane Reg Primate Res Ctr, New Orleans, LA 70112 USA
关键词
D O I
10.1089/088922201750102580
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Genetic variation of SIV env during the course of infection provides a large population pool that is continually shaped by selective forces in vivo and may influence the development of clinical disease, SAIDS-associated lymphoma (SAL) in the SIV-infected macaque is typically a clonal or oligoclonal mass of B cell origin, extranodal in anatomic distribution, in which SIV is restricted largely to infiltrating macrophages. To explore the degree of genetic variation in SIV env represented in SAL, a 480-bp DNA fragment containing the V1 region was PCR amplified from seven cases of SAL and from a nonneoplastic lymph node of an SIV-infected macaque, The nucleotide sequence of the V1 region was determined from at least 10 clones from multiple independent amplification reactions of each tissue. Overall, the degree of V1 variability within lymphomas was found not to be restricted but to resemble the heterogeneity reported in SIV-infected lymphoid and other tissues, V1 variation in the nonneoplastic lymph node was unexpectedly limited, perhaps related to the unusual disease condition associated with SAIDS in that animal. Unlike observations from SIV-infected tissues of animals without neoplastic disease, no increase was detected in the number of O- or N-linked glycosylation sites in the V1 regions isolated from lymphomas as compared with the original inoculum, These findings suggest that, within the microenvironment of the lymphoma, the immune evasion conferred by increased glycosylation may offer little selective advantage.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 50 条
  • [41] Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS
    Sato, Shuji
    Johnson, Welkin
    CURRENT HIV RESEARCH, 2007, 5 (06) : 594 - 607
  • [42] Simian immunodeficiency virus: possible effects of deworming and tuberculin extrapolated to HIV/AIDS
    Fincham, JE
    Adams, VJ
    Markus, MB
    VACCINE, 2003, 21 (19-20) : 2258 - 2259
  • [43] USE OF CLONED SIMIAN IMMUNODEFICIENCY VIRUS OF DEFINED SEQUENCE FOR STUDY OF AIDS PATHOGENESIS
    DESROSIERS, RC
    BURNS, DP
    KODAMA, T
    MORI, K
    KESTLER, HW
    MORRISON, HG
    GIBBS, JS
    DANIEL, MD
    RINGLER, DJ
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 310 - 310
  • [44] INDUCTION OF AIDS IN RHESUS-MONKEYS BY MOLECULARLY CLONED SIMIAN IMMUNODEFICIENCY VIRUS
    KESTLER, H
    KODAMA, T
    RINGLER, D
    MARTHAS, M
    PEDERSEN, N
    LACKNER, A
    REGIER, D
    SEHGAL, P
    DANIEL, M
    KING, N
    DESROSIERS, R
    SCIENCE, 1990, 248 (4959) : 1109 - 1112
  • [45] ASSESSING GENETIC-BASED THERAPIES FOR AIDS USING THE SIMIAN IMMUNODEFICIENCY VIRUS
    ENDRES, CL
    BERGQUAM, E
    AXTHELM, MK
    WONG, SW
    JOURNAL OF MEDICAL PRIMATOLOGY, 1995, 24 (03) : 141 - 144
  • [46] Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
    David T. Evans
    David H. O'Connor
    Peicheng Jing
    John L. Dzuris
    John Sidney
    Jack da Silva
    Todd M. Allen
    Helen Horton
    John E. Venham
    Richard A. Rudersdorf
    Thorsten Vogel
    C. David Pauza
    Ronald E. Bontrop
    Robert DeMars
    Alessandro Sette
    Austin L. Hughes
    David I. Watkins
    Nature Medicine, 1999, 5 : 1270 - 1276
  • [47] Retrospective analysis of clinical and laboratory factors associated with lymphoma in simian AIDS
    Fortgang, IS
    Srivastav, SK
    Baskin, GB
    Schumacher, PM
    Levy, LS
    LEUKEMIA & LYMPHOMA, 2004, 45 (01) : 161 - 169
  • [48] Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1
    Crise, B
    Li, Y
    Yuan, CC
    Morcock, DR
    Whitby, D
    Munroe, DJ
    Arthur, LO
    Wu, XL
    JOURNAL OF VIROLOGY, 2005, 79 (19) : 12199 - 12204
  • [49] Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
    Evans, DT
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Sidney, J
    da Silva, J
    Allen, TM
    Horton, H
    Venham, JE
    Rudersdorf, RA
    Vogel, T
    Pauza, CD
    Bontrop, RE
    DeMars, R
    Sette, A
    Hughes, AL
    Watkins, DI
    NATURE MEDICINE, 1999, 5 (11) : 1270 - 1276
  • [50] Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras
    Center, RJ
    Lebowitz, J
    Leapman, RD
    Moss, B
    JOURNAL OF VIROLOGY, 2004, 78 (05) : 2265 - 2276